A7 – Promotion of Clinical Trials – Balancing risk and benefit

As clinical researchers we are always seeking opportunities to boost recruitment into our clinical studies. This session will explore the risks and benefits of promoting clinical trials to raise community awareness and boost recruitment. What are the regulations, how does the MA Code apply, what are our obligations¬† to manage editorial conduct and where are the “grey areas” that need further discussion and evaluation?

 

Chairperson: Darryl Carrington, GlaxoSmithKline